BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2591264)

  • 21. [The content of copper in the tissues of patients with hepatolenticular degeneration].
    BAUMAN LK
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1960; 60():1141-5. PubMed ID: 13687972
    [No Abstract]   [Full Text] [Related]  

  • 22. Intrahepatocellular localization of copper in Wilson's disease.
    Yano M; Sakamoto N; Takikawa T; Hayashi H
    Nagoya J Med Sci; 1993 Mar; 55(1-4):131-7. PubMed ID: 8247102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Wilson's disease: a new gene and an animal model for an old disease.
    Cuthbert JA
    J Investig Med; 1995 Aug; 43(4):323-36. PubMed ID: 7552582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Current views on the pathogenesis of Wilson's disease].
    Szeliga J
    Pediatr Pol; 1973 Mar; 48(3):381-4. PubMed ID: 4571542
    [No Abstract]   [Full Text] [Related]  

  • 25. Studies on hepatolenticular degeneration; copper as the causative agent in the degeneration and dysfunction of electric tissue.
    HANSL N; HYMAN I; LUPARELLO T; ZIMDAHL WT
    J Lab Clin Med; 1956 Jul; 48(1):108-16. PubMed ID: 13332347
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of copper metabolism on neurological functions in Wistar and Wilson's disease model rats.
    Fujiwara N; Iso H; Kitanaka N; Kitanaka J; Eguchi H; Ookawara T; Ozawa K; Shimoda S; Yoshihara D; Takemura M; Suzuki K
    Biochem Biophys Res Commun; 2006 Oct; 349(3):1079-86. PubMed ID: 16970921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of drugs upon the copper metabolism in hepatolenticular degeneration and in normal subjects.
    ZIMDAHL WT; HYMAN I; STAFFORD WF
    J Lab Clin Med; 1954 May; 43(5):774-84. PubMed ID: 13163577
    [No Abstract]   [Full Text] [Related]  

  • 28. Inherited metabolic disease of the liver.
    Fink S; Schilsky ML
    Curr Opin Gastroenterol; 2007 May; 23(3):237-43. PubMed ID: 17414838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies of diagnosis and pathogenesis of Wilson's disease.
    Leung X; Chen R; Liu Z; Zhang Y
    Adv Exp Med Biol; 1995; 363():197-205. PubMed ID: 7618524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Copper in Alzheimer's disease: too much or too little?
    Quinn JF; Crane S; Harris C; Wadsworth TL
    Expert Rev Neurother; 2009 May; 9(5):631-7. PubMed ID: 19402774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic copper and metallothionein distribution in Wilson's disease (hepatolenticular degeneration).
    Nartey NO; Frei JV; Cherian MG
    Lab Invest; 1987 Oct; 57(4):397-401. PubMed ID: 3312808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Wilson's disease in the German Democratic Republic. II. Pathogenesis and clinical aspects].
    Lössner J; Bachmann H; Biesold D; Ruchholtz U; Storch W
    Z Gesamte Inn Med; 1980 Feb; 35(3):136-41. PubMed ID: 7395295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of the stable isotope 65Cu test for the screening of Wilson's disease in a family with two affected members.
    Merli M; Patriarca M; Loudianos G; Valente C; Riggio O; De Felice G; Petrucci F; Caroli S; Attili AF
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):270-5. PubMed ID: 9759594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The biochemistry of copper.
    Frieden E
    Sci Am; 1968 May; 218(5):103-14. PubMed ID: 4297207
    [No Abstract]   [Full Text] [Related]  

  • 35. [Study on therapeutical effect of treating hepatolenticular degeneration by the HLD-Tablet I].
    Hu W; Yang R
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1998 Jan; 18(1):12-4. PubMed ID: 11360563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experimental studies on the pathogenesis of hepatogenic encephalopathy.
    Mossakowski MJ
    Riv Patol Nerv Ment; 1978; 99(1):25-36. PubMed ID: 752896
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hepatolenticular degeneration. Present status of chemical pathology and treatment. I. Normal metabolism of copper and disorder of copper metabolism in hepatolenticular degeneration].
    BOUDIN G; PEPIN B
    Presse Med (1893); 1962 Apr; 70():1027-30. PubMed ID: 13871780
    [No Abstract]   [Full Text] [Related]  

  • 38. Reaction of brain copper proteins with sodium diethyldithiocarbamate in normal and in hepatolenticular degeneration.
    PORTER H; AINSWORTH S
    Proc Soc Exp Biol Med; 1958 Jun; 98(2):277-80. PubMed ID: 13554617
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies on the pathogenesis of hepatolenticular degeneration. I. Acid phosphatase activity in copper-loaded rat livers.
    Lindquist RR
    Am J Pathol; 1967 Oct; 51(4):471-81. PubMed ID: 6050756
    [No Abstract]   [Full Text] [Related]  

  • 40. Studies on copper metabolism. XIII. Hepatolenticular degeneration.
    CARTWRIGHT GE; HODGES RE; GUBLER CJ; MAHONEY JP; DAUM K; WINTROBE MM; BEAN WB
    J Clin Invest; 1954 Nov; 33(11):1487-501. PubMed ID: 13211803
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.